financetom
Business
financetom
/
Business
/
Walt Disney Likely Has Multiple Avenues of Potential Earnings Upside, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Walt Disney Likely Has Multiple Avenues of Potential Earnings Upside, UBS Says
Mar 27, 2024 10:53 AM

01:37 PM EDT, 03/27/2024 (MT Newswires) -- Walt Disney's ( DIS ) business model likely has several sources of potential earnings upside in the coming quarters, led by better results at its parks business, with additional help from the direct-to-consumers and content segments, according to UBS Securities.

These sources are expected to drive the media and entertainment giant's earnings estimates higher over the next several quarters, yielding a 25% three-year compound annual growth rate, UBS analysts John Hodulik, Batya Levi, and Christopher Schoell said in a note Wednesday.

The brokerage expects the parks segment's earnings before interest and taxes to grow by double-digit percentage annually in both the fiscal second quarter and full year amid strong US attendance. The company's spending plan is likely to drive high-single-digit or better EBIT growth in the business for "several years," the analysts said. "Despite the tougher comparisons, we expect the experiences segment to remain a high-growth and cash generative business for Disney ( DIS )," they said.

UBS sees the company's DTC segment becoming a "substantial" source of profits over the next few years. Subscriber growth, price hikes, and advertising ramp are expected to generate more than 20% three-year CAGR in segment sales. "The consolidation of Hulu in the US should also drive engagement and help streamline operations, boosting streaming margins," the trio wrote.

The brokerage expects Disney's ( DIS ) content segment to become profitable, with "incrementally higher" licensing revenue and improved box office with a new slate. "We expect Disney ( DIS ) to be more aggressive with content licensing without hurting the growth of streaming subscribers," the analysts said. "That said, the days when it was licensing its tentpole content to Netflix ( NFLX ) are likely over so the peaks are unlikely to be seen again."

The company's linear entertainment business is expected to continue to fall, though that will be "partly recaptured" within its sports segment and the new sports bundle, UBS wrote.

The firm increased its EPS outlook for Disney ( DIS ) by mid-single-digits from 2024 through 2026. It also raised its price target on the stock to $140 from $120, saying it continues to be "bullish" on the stock. Disney ( DIS ) shares have risen more than 30% since the start of 2024.

The upcoming shareholder vote amid activist pressure is expected to "add volatility" to Disney's ( DIS ) shares in the near term, the UBS analysts said. "The biggest risk in our view is potential management change were the activists to be successful in the bid for board seats," they wrote. "This could cause a downturn in the shares just as the benefits of (Disney ( DIS ) Chief Executive) Bob Iger's latest tenure are starting to take hold."

Price: 120.36, Change: +0.43, Percent Change: +0.36

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Takeda Pharmaceutical Unit Partners with HEALWELL AI for Real-World Evidence Analysis of Hereditary Angioedema
Takeda Pharmaceutical Unit Partners with HEALWELL AI for Real-World Evidence Analysis of Hereditary Angioedema
Jun 6, 2024
09:48 AM EDT, 06/06/2024 (MT Newswires) -- Takeda Pharmaceutical's ( TAK ) unit Takeda Canada has partnered with HEALWELL AI's subsidiary Pentavere Research Group to analyze real-world evidence for rare diseases in Canada, HEALWELL said Thursday. The focus of the collaboration will be on supporting patients with hereditary angioedema, or HAE, with normal C1 inhibitor, an ultra-rare condition marked by...
-- Nevada Copper Brief: Down Near 80% After Providing Update on Financing Efforts and Liquidity
-- Nevada Copper Brief: Down Near 80% After Providing Update on Financing Efforts and Liquidity
Jun 6, 2024
09:47 AM EDT, 06/06/2024 (MT Newswires) -- Price: 0.02, Change: -0.07, Percent Change: -77.78 ...
What's Going On With Sagimet Biosciences Stock On Thursday?
What's Going On With Sagimet Biosciences Stock On Thursday?
Jun 6, 2024
Sagimet Biosciences Inc ( SGMT ) presented data from its FASCINATE-2 Phase 2b clinical trial of denifanstat versus placebo in biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) patients at the European Association for the Study of the Liver (EASL) Congress. Related: What’s Going On With Fatty Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday? Sagimet’s lead drug candidate, denifanstat, is...
Instacart Board Approves $500 Million Buyback Program
Instacart Board Approves $500 Million Buyback Program
Jun 6, 2024
09:48 AM EDT, 06/06/2024 (MT Newswires) -- Instacart's (CART) board of directors approved a share repurchase program with the authorization to buy up to an aggregate of $500 million of the company's common stock, according to a regulatory filing released Thursday. Price: 32.89, Change: +1.94, Percent Change: +6.28 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved